Antares Pharma
ATRS
$5.59
Share price
0.00%
Change (1 day)
27.63%
Change (1 year)
Categories
P/S ratio for Antares Pharma (ATRS)
P/S ratio at the end of 2021: 3.30
According to Antares Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is . At the end of 2021 the company had a P/S ratio of 3.30.
P/S ratio history for Antares Pharma from 2001 to 2021
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2021 | 3.30 | -25.78% |
| 2020 | 4.45 | -29.09% |
| 2019 | 6.27 | -8.29% |
| 2018 | 6.84 | 19.52% |
| 2017 | 5.72 | -17.35% |
| 2016 | 6.92 | 68.62% |
| 2015 | 4.10 | -67.88% |
| 2014 | 12.8 | -54.24% |
| 2013 | 27.9 | 31.34% |
| 2012 | 21.3 | 53.62% |
| 2011 | 13.8 | 23.97% |
| 2010 | 11.2 | -0.53% |
| 2009 | 11.2 | 152.52% |
| 2008 | 4.44 | -45.64% |
| 2007 | 8.17 | -45.47% |
| 2006 | 15.0 | -49.99% |
| 2005 | 30.0 | 50.83% |
| 2004 | 19.9 | 268.39% |
| 2003 | 5.39 | 376.18% |
| 2002 | 1.13 | -88.31% |
| 2001 | 9.69 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.88 | N/A | 🇺🇸 USA |
 Pfizer PFE | 2.68 | N/A | 🇺🇸 USA |
 Eli Lilly LLY | 21.1 | N/A | 🇺🇸 USA |
 Becton Dickinson BDX | 3.56 | N/A | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | 2.89 | N/A | 🇺🇸 USA |
 Retractable Technologies RVP | 0.7458 | N/A | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1.01 | N/A | 🇮🇱 Israel |
 West Pharmaceutical WST | 9.21 | N/A | 🇺🇸 USA |